Sleep apnea and high blood pressure | VivaRespire

Medical notice: This content is informational. Sleep apnea must be diagnosed and treated under medical supervision.
VivaRespire is a specialist online CPAP store. We do not offer INAMI/RIZIV reimbursement. For more information, see our page CPAP reimbursement in Belgium.

Sleep Apnea and High Blood Pressure: The Hidden Link

Between 30 and 40% of hypertensive patients have undiagnosed obstructive sleep apnea (OSA). Sleep apnea is now recognised as the leading secondary cause of hypertension by the European cardiology guidelines (ESC/ESH 2023) - ahead of kidney disease and hormonal disorders. If your blood pressure resists medical treatment, your sleep deserves investigation.

Indicator Figure Source
Hypertensive patients with undiagnosed OSA 30-40% Wisconsin Sleep Cohort, JAMA 2000
Resistant hypertension cases with associated OSA 60-83% HIPARCO, Lancet 2013
Risk of hypertension if OSA untreated ×2 Peppard et al., JAMA 2000
Systolic reduction under CPAP therapy 2-10 mmHg Meta-analyses Montesi et al., 2012

How Sleep Apnea Causes High Blood Pressure: The Mechanism

With each apnea event, breathing stops - sometimes for 30 seconds or more. Blood oxygen levels drop sharply. The brain, sensing this oxygen deficit, triggers an emergency response via the sympathetic nervous system: it releases cortisol and adrenaline to force a micro-arousal and restart breathing.

The Apnea → Hypertension Cycle in 4 Steps

  1. Apnea → oxygen drop: the pharynx closes, breathing stops. Oxygen saturation (SpO₂) can fall below 90% during severe events.
  2. Sympathetic nervous system activation: the brain triggers a stress response. Cortisol and adrenaline are released within seconds into the bloodstream.
  3. Vasoconstriction and blood pressure spike: blood vessels contract, the heart accelerates. Blood pressure can surge by 30 to 40 mmHg during each micro-arousal.
  4. Chronic daytime hypertension: repeated 30 to 100 times per night, this mechanism eventually keeps blood pressure permanently elevated - even during the day.

Nocturnal Hypertension and the Non-Dipping Profile

Normally, blood pressure drops by approximately 10 to 20% during sleep - known as the dipping profile. This nocturnal dip is protective for the heart and arteries.

In apnea patients, repeated micro-arousals keep the sympathetic nervous system in permanent activation throughout the night. Blood pressure does not fall, or does so insufficiently - this is called a non-dipping profile. It is an indirect indicator of sleep apnea and is associated with significantly higher cardiovascular risk: stroke, heart failure, atrial fibrillation.

A 24-hour ambulatory blood pressure monitoring (ABPM) revealing a non-dipping profile should systematically prompt investigation for sleep apnea.

Resistant Hypertension: Sleep Apnea Found in 60-83% of Cases

Resistant hypertension is defined as blood pressure that remains uncontrolled despite three or more antihypertensive medications at optimal doses (including a diuretic). It is a frequent and frustrating situation for both patients and physicians.

Sleep apnea is found in 60 to 83% of patients with resistant hypertension (HIPARCO, Lancet 2013). It is often the primary underlying cause that has not yet been investigated. The ESC/ESH 2023 guidelines explicitly recommend exploring sleep disorders in this context.

Warning signs that should prompt evaluation:

  • High blood pressure despite 3 or more medications
  • Elevated nocturnal blood pressure on ABPM
  • Non-dipping profile on ABPM
  • Loud snoring reported by a partner
  • Persistent fatigue despite a full night's sleep
  • Overweight or obesity (BMI > 30)
  • Large neck circumference (> 43 cm in men, > 38 cm in women)
  • Unexplained daytime sleepiness

The Vicious Cycle: Apnea → Hypertension → Cardiovascular Risk

Sleep apnea and hypertension feed each other in a vicious cycle with serious consequences:

  • Untreated apnea → chronic hypertension through repeated sympathetic activation
  • Chronic hypertension → vascular remodelling: arterial wall thickening, increased stiffness
  • Vascular remodelling → major cardiovascular risk: stroke, myocardial infarction, heart failure, atrial fibrillation
  • Cardiovascular risk worsened by apnea: intermittent hypoxia, systemic inflammation, endothelial dysfunction

A reduction of just 5 mmHg in systolic pressure translates to a 14% decrease in stroke risk and a 9% decrease in heart attack risk over the long term - making apnea treatment clinically relevant even when the blood pressure effect appears modest in absolute terms.

Does CPAP Lower Blood Pressure?

Yes, but with realistic expectations. Meta-analyses show an average reduction of 2 to 10 mmHg in systolic pressure after several months of consistent CPAP use. The effect is:

  • Dose-dependent: the more you use CPAP (minimum 4 hours per night, ideally 6 or more), the greater the blood pressure reduction
  • More pronounced in patients with severe apnea (AHI > 30) and those with significant daytime sleepiness
  • Particularly significant for resistant hypertension: the HIPARCO trial (Lancet 2013) showed an additional reduction of more than 3 mmHg in nocturnal systolic pressure after 12 weeks of CPAP
  • Complementary to antihypertensives: CPAP does not replace medication - it addresses the cause of apneas while medication acts directly on blood pressure
Early improvements in nocturnal blood pressure (return to a dipping profile) are often seen after 4 to 8 weeks of regular CPAP use. Effects on daytime blood pressure generally take 3 to 6 months.

What to Do If You Are Hypertensive and Suspect Sleep Apnea?

The recommended steps are straightforward:

  1. Speak to your GP or cardiologist, especially if your blood pressure resists treatment or if a partner reports loud snoring with breathing pauses.
  2. Request a nocturnal respiratory polygraphy - the reference diagnostic test for sleep apnea. It is performed at an accredited sleep centre and covered by INAMI/RIZIV under specific conditions.
  3. If the diagnosis is confirmed, CPAP therapy will be prescribed. You can then freely choose your device - which is exactly what VivaRespire offers.

Why Buy Your CPAP from VivaRespire?

In Belgium, the INAMI-approved system provides CPAP devices via accredited sleep centres - the patient does not own the device. VivaRespire serves patients who wish to own their own device: immediate start after prescription, freedom to choose from leading brands (ResMed, Philips Respironics, Löwenstein), or acquisition of a second travel device.

Our most popular auto CPAP devices for hypertensive patients starting therapy or looking to complete their equipment:

Browse our full range: Auto CPAP | All CPAP Devices

Learn more: AHI - Apnea-Hypopnea Index | Home Sleep Test | Sleep Apnea Symptoms

Follow us

Top